Differential Expression of SMAD Genes and S1PR1 on Circulating CD4+ T Cells in Multiple Sclerosis and Crohn’s Disease
Open Access
- 19 January 2020
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (2), 676
- https://doi.org/10.3390/ijms21020676
Abstract
The Th17 immune response plays a key role in autoimmune diseases such as multiple sclerosis (MS) and inflammatory bowel disease (IBD). Expression of Th17-related genes in inflamed tissues has been reported in autoimmune diseases. However, values are frequently obtained using invasive methods. We aimed to identify biomarkers of MS in an accessible sample, such as blood, by quantifying the relative expression of 91 Th17-related genes in CD4+ T lymphocytes from patients with MS during a relapse or during a remitting phase. We also compared our findings with those of healthy controls. After confirmation in a validation cohort, expression of SMAD7 and S1PR1 mRNAs was decreased in remitting disease (–2.3-fold and –1.3-fold, respectively) and relapsing disease (–2.2-fold and –1.3-fold, respectively). No differential expression was observed for other SMAD7-related genes, namely, SMAD2, SMAD3, and SMAD4. Under-regulation of SMAD7 and S1PR1 was also observed in another autoimmune disease, Crohn’s disease (CD) (−4.6-fold, -1.6-fold, respectively), suggesting the presence of common markers for autoimmune diseases. In addition, expression of TNF, SMAD2, SMAD3, and SMAD4 were also decreased in CD (–2.2-fold, –1.4-fold, –1.6-fold, and –1.6-fold, respectively). Our study suggests that expression of SMAD7 and S1PR1 mRNA in blood samples are markers for MS and CD, and TNF, SMAD2, SMAD3, and SMAD4 for CD. These genes could prove useful as markers of autoimmune diseases, thus obviating the need for invasive methods.This publication has 50 references indexed in Scilit:
- Th17 Cells in Immunopathogenesis and treatment of rheumatoid arthritisInternational Journal of Rheumatic Diseases, 2013
- The inhibition of Th17 immune response in vitro and in vivo by the carbosilane dendrimer 2G-NN16Biomaterials, 2012
- The many faces of Th17 cellsCurrent Opinion in Immunology, 2011
- TGF-β signaling is altered in the peripheral blood of subjects with multiple sclerosisJournal of Neuroimmunology, 2011
- TRAF6 inhibits Th17 differentiation and TGF-β–mediated suppression of IL-2Blood, 2010
- Smad7 in T cells drives T helper 1 responses in multiple sclerosis and experimental autoimmune encephalomyelitisBrain, 2010
- Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosusArthritis Research & Therapy, 2010
- Transforming growth factor-β induces development of the TH17 lineageNature, 2006
- Non-Smad TGF-β signalsJournal of Cell Science, 2005
- Blood transcriptional signatures of multiple sclerosis: Unique gene expression of disease activityAnnals of Neurology, 2004